This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Cannabis Global Applying THC-V Production Techniques to CBN
Company continues work with rare cannabinoids through Project Varin research program.
Cannabis Global, Inc. says it has successfully applied production techniques developed for tetrahydrocannabivarin (THC-V) to cannabinol (CBN), another rare cannabinoid the company believes has growth potential as a new cannabinoid-based products market.
This discovery results from continued work on the company's "Project Varin" initiative, a research and development project the company launched in January 2020 to manufacture new nanotechnologies, infusions and consumer products based on rare cannabinoids. To date, the project has yielded product development and production methodology breakthroughs Cannabis Global believes will enable more effective commercialization of products based on rare cannabinoids.